Association of anticoagulant choice with death in the primary treatment of noncancer venous thromboembolism: Medicare 2011-2018 - Top-Institutions - MDSpire

Association of anticoagulant choice with death in the primary treatment of noncancer venous thromboembolism: Medicare 2011-2018

  • By

  • Rob F Walker

  • Neil A Zakai

  • Richard F Maclehose

  • Faye L Norby

  • Alvaro Alonso

  • Pamela L Lutsey

  • August 9, 2024

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Pharmacology
    • Clinical Research

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Hematology
    • Pharmacoepidemiology
    • Cardiology

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Hematology
    • Pharmacology
    • Internal Medicine

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Hematology
    • Epidemiology
    • Pharmacoepidemiology

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Hematology
    • Pharmacology
    • Clinical Epidemiology

Original Source(s)

Association of anticoagulant choice with death in the primary treatment of noncancer venous thromboembolism: Medicare 2011-2018

  • by Rob F Walker, Neil A Zakai, Richard F Maclehose, Faye L Norby, Alvaro Alonso, Pamela L Lutsey

  • August 9, 2024

Related Content

Immunological research landscapes and emerging immune mechanisms in HIV/HBV co-infection: a bibliometric analysis (2014–2024)

Mechanisms and Therapeutic Promise of Electroacupuncture for Non-Alcoholic Fatty Liver Disease

Familial Hypobetalipoproteinemia as a Frequently Overlooked Factor in Pediatric Fatty Liver Disease